Rijon, Howell Gaden M.
HRN: 22-85-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2023
CEFUROXIME 1.5GM (VIAL)
04/02/2023
04/08/2023
IV
900 Mg
Q8hrs
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes